Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
63 hedge funds and large institutions have $27.5M invested in Enzo Biochem, Inc. in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
92% less call options, than puts
Call options by funds: $5K | Put options by funds: $59K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LTFS
51
Ladenburg Thalmann Financial Services
Miami,
Florida
| $8K | +$8.28K | +3,750 | New |
|
|
TJHA
52
Thomas J. Herzfeld Advisors
Miami Beach,
Florida
| $6K | +$6.62K | +3,000 | New |
|
53
Bank of Montreal
Toronto,
Ontario, Canada
| $5K | +$5.39K | +2,440 | New |
|
54
Wells Fargo
San Francisco,
California
| $4K | +$4.98K | +2,255 | New |
|
55
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3K | +$3.09K | +1,398 | New |
|
|
HCM
56
Horrell Capital Management
Little Rock,
Arkansas
| $2K | +$2.31K | +1,048 | New |
|
|
TF
57
Tompkins Financial
Ithaca,
New York
| $2K | +$2.32K | +1,050 | New |
|
|
CPA
58
Cowen Prime Advisors
New York
| $1K | +$534 | +242 | New |
|
59
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | +$550 | +249 | New |
|
60
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$662 | +300 | New |
|
|
HI
61
Hudock Inc
Williamsport,
Pennsylvania
| $1K | +$839 | +380 | New |
|
|
NFA
62
Nationwide Fund Advisors
Columbus,
Ohio
| $1K | +$1.1K | +500 | New |
|
63
Citigroup
New York
| – | +$44 | +20 | New |
|
ENZ Hedge Fund Activity: Q2 2013 in Review
63 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q2 2013, worth a combined $27.5M.
Buyers outnumbered sellers: 63 funds opened new ENZ positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.
- 63 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $27.5M of Enzo Biochem, Inc. stock for Q2 2013.
- 63 funds opened new Enzo Biochem, Inc. positions in Q2 2013 and 0 closed out, a net change of +63 holders.
Based on aggregated 13F filings for Q2 2013.